Clinical Trial

Transcutaneous Auricular Vagus Nerve Stimulation on Post-Herpetic Neuralgia

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the therapeutic efficacy of transcutaneous auricular vagus nerve stimulation (taVNS) in the treatment of patients with post-herpetic neuralgia (PHN). Participants will receive taVNS in addition to standard care. The study aims to determine whether taVNS can provide significant pain relief and improve quality of life in PHN patients.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-12; most recent amendment 2026-03-16.
Status change: Not Yet Recruiting → Recruiting 2025-08-14
Trial Details
NCT Number NCT07123987
Lead Sponsor Mohamed Hosny Ismail Easa
Conditions Post Herpetic Neuralgia (PHN)
Enrollment 34 participants
Start Date 2025-09-07
Primary Completion 2026-09-09 (estimated)
Study Completion 2026-09-09 (estimated)
Updated on ClinicalTrials.gov 2026-03-18